Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.085
-0.190 (-5.80%)
Nov 3, 2026, 4:08 PM HKT

HKG:2591 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
1,40913,997--
Market Cap Growth
-89.91%---
Enterprise Value
40313,255--
Last Close Price
3.0830.64--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
PS Ratio
7.9695.64--
PB Ratio
1.3011.94--
P/TBV Ratio
1.3212.19--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
2.2890.57--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.160.160.010.07
Net Debt / Equity Ratio
-0.92-0.99-0.99-0.92
Net Debt / EBITDA Ratio
2.623.064.500.88
Net Debt / FCF Ratio
2.403.294.723.67
Asset Turnover
0.140.11--
Inventory Turnover
0.400.20--
Quick Ratio
3.142.675.821.94
Current Ratio
3.502.936.072.66
Return on Equity (ROE)
-41.16%-36.91%-23.27%-
Return on Assets (ROA)
-19.04%-17.30%-11.61%-
Return on Capital Employed (ROCE)
-35.70%-32.50%-23.80%-100.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-27.66%-2.71%--
FCF Yield
-29.69%-2.51%--
Buyback Yield / Dilution
-7.64%-3.44%-9.63%-